MedPath

Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.

Phase 1
Recruiting
Conditions
novel coronavirus pneumonia (COVID-19)
Registration Number
ITMCTR2000003137
Lead Sponsor
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with mild, common, and severe neocoronary pneumonia;
(2) Those who meet the diagnostic criteria for insomnia with traditional Chinese medicine;
(3) Those who meet the diagnostic criteria for insomnia with western medicine;
(4) Those aged 18-75 years;
(5) Agree to receive treatment, and the patient or legal guardian signs the information through mobile phone software and voice authorization Consent;
(6) During this period, the patient did not take drugs and other treatments for the disease, or the drug dose did not increase based on the original treatment.

Exclusion Criteria

(1) Patients who are unwilling to cooperate during the treatment;
(2) Patients with neocoronary pneumonia converted to critically ill during the treatment;
(3) Patients with mental illness who have severe primary diseases such as hematopoietic system, liver, cardiovascular, lung and kidney;
(4) Those who are allergic to alcohol and tape.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
depression;insomnia;anxiety;comfort;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath